These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1866139)

  • 1. Dissolution of intraocular fibrinous exudate by streptokinase.
    Cherfan GM; el Maghraby A; Tabbara KF; Nasr Y; Hassan H
    Ophthalmology; 1991 Jun; 98(6):870-4. PubMed ID: 1866139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution of pseudophakic fibrinous exudate with intraocular streptokinase.
    Mullaney PB; Wheeler DT; al-Nahdi T
    Eye (Lond); 1996; 10 ( Pt 3)():362-6. PubMed ID: 8796163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of fibrin pupillary-block glaucoma after pars plana vitrectomy with intravitreal gas injection.
    Lewis H; Han D; Williams GA
    Am J Ophthalmol; 1987 Feb; 103(2):180-2. PubMed ID: 3812619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator.
    Jaffe GJ; Lewis H; Han DP; Williams GA; Abrams GW
    Am J Ophthalmol; 1989 Aug; 108(2):170-5. PubMed ID: 2502924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.
    Schmitz K; Greite JH; Bartenschlager EM
    Ger J Ophthalmol; 1995 Mar; 4(2):75-9. PubMed ID: 7795512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of anterior chamber fibrin following cataract surgery with tissue plasminogen activator.
    Lesser GR; Osher RH; Whipple D; Abrams GW; Cionni RJ
    J Cataract Refract Surg; 1993 Mar; 19(2):301-5. PubMed ID: 8487179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tissue plasminogen activator in treatment of fibrinous membranes after cataract surgery].
    Oficjalska-Młyńczak J; Marek J; Zajac-Pytrus H; Nizankowska MH; Koziorowska M
    Klin Oczna; 1996; 98(6):423-5. PubMed ID: 9340414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
    Erol N; Ozer A; Topbas S; Yildirim N; Yurdakul S
    Ophthalmic Surg Lasers Imaging; 2003; 34(6):451-6. PubMed ID: 14620747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of anterior chamber clearance via the pars plana in pseudophakic endophthalmitis.
    Patil R; Talwar D; Verma LK; Sharma YR; Nainiwal S; Azad RV; Tewari HK
    Ophthalmologica; 2003; 217(2):104-6. PubMed ID: 12592046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extracapsular cataract extraction and implantation in the capsular sac during vitrectomy in diabetics].
    Pagot V; Gazagne C; Galiana A; Giraud MA; Malecaze F; Mathis A
    J Fr Ophtalmol; 1991; 14(10):523-8. PubMed ID: 1791275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery.
    Siatiri H; Beheshtnezhad AH; Asghari H; Siatiri N; Moghimi S; Piri N
    Br J Ophthalmol; 2005 Nov; 89(11):1458-61. PubMed ID: 16234453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety profile of the intravitreal streptokinase-plasmin complex as an adjunct to vitrectomy in the rabbit.
    Hermel M; Mahgoub M; Youssef T; Azrak MI; Raza H; Alldredge C; Trese M; Williams GA; Hartzer M
    Graefes Arch Clin Exp Ophthalmol; 2006 Aug; 244(8):996-1002. PubMed ID: 16365737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of postcataract fibrinous membranes with tissue plasminogen activator.
    Moon J; Chung S; Myong Y; Chung S; Park C; Baek N; Rhee S
    Ophthalmology; 1992 Aug; 99(8):1256-9. PubMed ID: 1513579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue plasminogen activator for postvitrectomy fibrin formation.
    Jaffe GJ; Abrams GW; Williams GA; Han DP
    Ophthalmology; 1990 Feb; 97(2):184-9. PubMed ID: 2109297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal endothelial cell damage associated with intraocular gas tamponade during pars plana vitrectomy.
    Matsuda M; Tano Y; Inaba M; Manabe R
    Jpn J Ophthalmol; 1986; 30(3):324-9. PubMed ID: 3784144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pars plana vitrectomy, phacoemulsification and intraocular lens implantation. Comparison of clinical complications in a combined versus two-step surgical approach.
    Treumer F; Bunse A; Rudolf M; Roider J
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):808-15. PubMed ID: 16328429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of pediatric cataract surgery with intraocular injection of triamcinolone acetonide: Randomized controlled trial.
    Allam G; Ellakkany R; Ellayeh A; Mohsen T; Abouelkheir HE; Gaafar W
    Eur J Ophthalmol; 2018 Nov; 28(6):633-638. PubMed ID: 29619840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
    Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
    Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of results of combined pars plana vitrectomy and cataract removal].
    Wilczyński M; Pikulski Z; Dziegielewski K; Omulecki W
    Klin Oczna; 2005; 107(4-6):252-5. PubMed ID: 16118930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenetic analysis of postoperative protein concentration and cell count of fibrin exudate in the anterior chamber of the eye with a posterior chamber lens].
    Tsurimaki Y; Sawa M; Shimizu H
    Nippon Ganka Gakkai Zasshi; 1988 Oct; 92(10):1690-5. PubMed ID: 3213773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.